𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Session 13 Primary metabolism

✍ Scribed by T. J. Daniell; R. Edwards; W. R. Deppert; E. Wagner; M. Desimone; A. Henke; A. Diaz; H. Maza; B. Gonzalez-moro; M. Lacuesta; C. Gonzalez-murua; A. Muñoz-rueda; P. Du Jardin; R. Viola; F. Wyzen; J. Rojas-Beltran; A. J. Gordon; E. P. Harrison; F. R. Minchin; I. Hagima; N. N. Saulescu; M. Hardegger; V. Šebková; C. Unger; K. Lorenz; S. Lienhard; A. Sturm; E. O. Leidi; D. N. Rodriguez; A. Moing; A. J. Escobar-Gutierrez; J. P. Gaudillere; S. Pereira; C. Fernandes; D. Pinto; O. Figueira; S. Paiva; R. Salema; G. N. Rudenskaya; E. A. Bogdanova; L. P. Revina; B. N. Golovkin; V. M. Stepanov; J. Vicente-carbajosa; L. Oñate; B. Lama; E. Gonzalez; P. Carbonero; Z. Voráčková; H. Lipavská; R. M. Wallsgrove; O. V. Yakovleva; O. P. Bykova; D. Scainelli; R. Iona’; E. Nielsen; G. Forlani; S. Seele; P. Ziegler; E. Beck; O. Valentová; Z. Novotná; J. Káš; J. Daussant; C. Thévenot; L. H. W. Van Der Plas; J. Krook; C. Dukema; J. J. Zwiazek; C. Latt


Book ID
105660900
Publisher
Springer Netherlands
Year
1994
Tongue
English
Weight
550 KB
Volume
36
Category
Article
ISSN
0006-3134

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Session 13: Miscellaneous
📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 121 KB

Increased glucose metabolism of inflammatory tissues is the main source of false positive FDG-PET findings in oncology. For this reason, we have tested whether the selectivity of sigma receptor ligands for tumor versus inflammation is higher than that of FDG and FLT. The sigma receptor is strongly o

Session 14 Secondary metabolism
✍ A. Baumert; W. Maier; D. Gröger; O. P. Bykova; O. V. Yakovleva; I. I. Chemesova; 📂 Article 📅 1994 🏛 Springer Netherlands 🌐 English ⚖ 561 KB
Session 13: Peripheral tumours
📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 French ⚖ 718 KB

Introduction: Prostate Specific Membrane Antigen (PSMA) is highly expressed on the surface of prostate carcinomas. Previously, we demonstrated successful PET imaging of PSMA-expressing xenografts using the urea-based PSMA inhibitors [ 11 C]DCMC (Clin Cancer Res 2005; 11:1022), and [ 18 F]DCFBC (J Nu